|
Apr 09
2012
|
I Hope This Finds All of You Well and Enjoying EasterPosted by Stan Moore in Untagged |

NEWSLETTERS & RECOMMENDATIONS - April 8, 2012
Dear Friends and Fellow Traders,
Friday morning shows us "Rhythm" and "New Era Trading" at its possible best. I've been preaching hedging and parlaying trading techniques for over seven years now. It's the reason I un-retired in late 2005. Because the market is very overbought and vulnerable we find we must hedge now more than ever. I love the combination of long puts and long E-minis when the market is in rally mode because the unwanted puts are a bit cheaper.
However, when markets sell-off as they did last week we go long calls and short E-minis. Thursday morning we could have bought calls, the 140s as low as $0.07. Before expiring worthless the calls traded as high as $0.36 for a possible 5 Bagger in a few hours plus hedged profits as well.
Since Friday was a holiday there was no trading of options going into Friday's job numbers release. So unless you were long the April 14 140s ATM expiring calls near $0.80 you missed a great hedged trade.
I just wanted to impress upon you just how great this S&P really is. GS just raised the Friday jobs # Thursday morning from 175,000 to 200,000 setting up the market for a negative number surprise because a good number was now already in the market anywhere over 1390-95. Normally with a Friday trade we could have been long ATM 140 calls say $0.25-.30 not $0.07 a still perfectly good throwaway trade. We would have been short E-minis in the early Friday morning session anywhere over 1390 scaling in more higher where they were trading in front of the 8:30 number.
Surprise, the # disappoints! You lose $3,000 on 100 calls but you make between $20,000 and $30,000 on the E-mini hedge of 20-30 contracts per 100 options. (Scale for your account size.) That's what we do every week. Just looking for this trade and believe me we get it often enough. See a few earlier trading/training videos I made. By the way those 100 calls were more than already paid for with the many Wednesday/Thursday hedges.
This is what NET can become for you. It's a money machine if you just position yourself in front of market moving news enough of the time. I setup all these trades in the Chat Room as well as with Alert Emails ahead of time.
The markets will open much lower Monday but hopefully we can now start to look forward to QE3 once more. We're still selling rallies, getting long puts and long E-minis then on pronounced weakness and in large support areas we'll go long calls and short E-minis.
Here's some more great information about BioTime. Enjoy!! I just received this today. I will be at BioTime offices in San Francisco Mon/Tues, 4/16 and 4/17:
| Dear Technology Profits Reader, I enjoyed this week's trip to the Personalized Life Extension Conference in San Francisco. Part of the pleasure was meeting some of you, my readers. One thing I noticed was how extraordinarily well-informed Agora subscribers are compared with the “general population.” It truly is a privilege serving you. Thanks for attending the event and for the great conversation. I think Patrick Cox's Saturday presentation on new life-extension technologies pretty much brought the house down. Patrick had only half an hour to condense and present the latest breakthroughs to the audience - and a fast-paced half hour it was. It mirrored the rapid acceleration in life-extension technology happening right now. Another outstanding presentation was given by Sierra Sciences' president and CEO William H. Andrews, Ph.D. Andrews' specialty is telomeres - those “tips” that sit on the ends of our DNA strands. As we get older, the average length of our telomeres shortens, leading to aging and age-related disease. Andrews' company specializes in researching and developing ways to reverse that process. His motto is “cure aging or die trying.” On Sunday, John Mauldin of Millennium Wave Investments regaled the audience with the latest news in stem cell technology and cancer therapies. He talked about the first available fruits being harvested from stem cell research by International Stem Cell Corp and BioTime Inc.
Speaking of BioTime, Patrick and I personally toured its labs on Monday. BioTime is just across San Francisco Bay from the convention center. The San Francisco Bay Area is simply amazing in terms of the sheer number of biotechnology companies headquartered there. Here is a picture of a map of the area I took while there. It reads like a “who's who” of biotech: While there, I was just an observer, but Patrick was a lab rat! BioTime received some of Patrick's cells in order to demonstrate how it can transform them into stem cells used to rejuvenate the cardiovascular system. Agora Financial had a film crew on the scene. Our executive publisher, Addison Wiggin, is putting together a documentary on America's comeback. Breakthrough medical technology will be a huge part of that. The technology is astonishing to witness firsthand. When it goes live, all that will be necessary to get the process started from a patient's perspective is a few minutes at a dermatologist's office. We visited a dermatologist near BioTime's headquarters, where a small bit of Patrick's skin was removed from under his arm. The physician gingerly placed it into a flask and packed it into a Styrofoam cooler for transport to BioTime's lab: Skin cells in hand, we drove to BioTime, located just a few minutes away. BioTime's CEO, Dr. Michael West, explained that skin cells are more durable and ready to propagate in culture than other cell types. This makes them easier to work with. As the head of one of the world's leading regenerative medicine companies, Dr. West is immersed in the science of stem cells. When we arrived at the lab, Dr. West donned a white lab coat to prepare to work some magic on Patrick's cells. He teased out cells from between the collagen fibers that form part of skin's structure and bathed them in a growth medium prior to placement inside of an incubator. “Begun, the clone wars have,” Patrick joked. “I think one Patrick Cox is plenty,” I shot back: Once enough new cells have grown in culture, Dr. West's labs can transform them into stem cells. BioTime has pioneered in the discovery of how to flip the genetic switches needed to perform the conversion. Dr. West has also developed the technology to lengthen the telomeres in adult cells. Not only will these cells be able to turn into any type of tissue in the body, they will also be biologically young. This, as I mentioned, includes the cells of the cardiovascular system. Cardiovascular disease is the No. 1 killer in developed nations like the U.S. What will the world be like when we can reboot aging hearts and arteries, restoring them to youthful health? An interesting question, isn't it? The implications of this question really hit me in a personal way on the way back from San Francisco. As I drove home from the airport on Tuesday, my father called me to inform me that my grandfather had suffered a heart attack. I drove across the state yesterday to spend some time with him at the hospital. Grandfather is 82 now, and it is difficult to look at the strong, healthy man I remember from my childhood sitting in a hospital bed crisscrossed with tubes and wires. The doctor said he was lucky. The heart attack wasn't severe enough to cause real damage and hospital tests revealed the true extent of the disease. He'll be undergoing a quadruple bypass surgery early next week. I look forward to the day when these kinds of events -- caused by aging cardiovascular systems -- will be things of the past. As biotechnology investors, not only can we profit, but we can help hasten the day. Ad lucrum per scientia (toward wealth through science), Ray Blanco |
Remember I'm here to help you make all the dollars you desire.
Continue to enjoy your high Holy days.
Stan Moore
702.685.7325




